Posts

Crystal clear? G 2/21 applied to polymorph patents (T 1994/22)

The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)

Make no bones about it: The "credibility test" has no place in the novelty assessment of second medical use claims (T 0558/20)